吸烟与戒烟对溃疡性结肠炎疾病结局的影响:一项全国性人群研究
该研究基于全国代表性临床研究数据库,纳入2005-2016年新诊断的6754例溃疡性结肠炎(UC)患者,按诊断前2年吸烟状态分为从不吸烟、已戒烟和吸烟者,比较各组激素使用、激素依赖、硫嘌呤使用、住院和结肠切除术风险。结果显示吸烟者与从不吸烟者上述结局风险相似,持续吸烟与诊断后戒烟者结局亦无显著差异,结论为UC患者应被告知不要吸烟。
要点
- 吸烟者与从不吸烟者UC患者的激素依赖、硫嘌呤使用、住院和结肠切除风险相似。
- 持续吸烟与诊断后2年内戒烟者的疾病结局无显著差异。
- 戒烟未伴随更差的疾病病程,原文建议UC患者被告知不要吸烟。
核心结论
- 吸烟者与从不吸烟者UC患者的疾病发作、硫嘌呤使用、激素依赖、住院和结肠切除结局相似。
- 戒烟与更差疾病病程无关,原文指出吸烟相关风险超过任何获益,UC患者应被告知不要吸烟。
研究设计与样本
- 使用全国代表性临床研究数据库识别2005-2016年新发UC病例。
- 共纳入6754例有新诊断UC且有吸烟状态数据的患者,其中878例诊断时为吸烟者;按诊断前2年吸烟状态分为从不吸烟、已戒烟和吸烟者,并定义持续吸烟与诊断后2年内戒烟亚组。
主要发现
- 吸烟者与从不吸烟者相比,激素需求性发作OR 1.16(95%CI 0.92-1.25),硫嘌呤使用HR 0.84(95%CI 0.62-1.14),激素依赖HR 0.85(95%CI 0.60-1.11),住院HR 0.92(95%CI 0.72-1.18),结肠切除HR 0.78(95%CI 0.50-1.21)。
- 持续吸烟者与诊断后戒烟者在发作、硫嘌呤使用、激素依赖、住院和结肠切除方面无显著差异。
临床怎么用
- 原文结论为UC患者应被告知不要吸烟,因吸烟相关风险超过任何获益。
- 戒烟未伴随更差疾病病程,可据此向患者说明戒烟不增加疾病恶化风险。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Smokers are less likely to develop ulcerative colitis (UC) but the impact of smoking and subsequent cessation on clinical outcomes in UC is unclear. AIM: To evaluate the effect of smoking status and smoking cessation on disease outcomes. METHODS: Using a nationally representative clinical research database, we identified incident cases of UC during 2005-2016. Patients were grouped as never-smokers, ex-smokers and smokers based on smoking status recorded in the 2 years preceding UC diagnosis. We defined subgroups of persistent smokers and smokers who quit within 2 years after diagnosis. We compared the rates of overall corticosteroid use, corticosteroid-requiring flares, corticosteroid dependency, thiopurine use, hospitalisation and colectomy between these groups. RESULTS: We identified 6754 patients with a new diagnosis of UC over the study period with data on smoking status, of whom 878 were smokers at diagnosis. Smokers had a similar risk of corticosteroid-requiring flares (OR 1.16, 95% CI 0.92-1.25), thiopurine use (HR 0.84, 95% CI 0.62-1.14), corticosteroid dependency (HR 0.85, 95% CI 0.60-1.11), hospitalisation (HR 0.92, 95% CI 0.72-1.18) and colectomy (HR 0.78, 95% CI 0.50-1.21) in comparison with never-smokers. Rates of flares, thiopurine use, corticosteroid dependency, hospitalisation and colectomy were not significantly different between persistent smokers and those who quit smoking after a diagnosis of UC. CONCLUSIONS: Smokers and never-smokers with UC have similar outcomes with respect to flares, thiopurine use, corticosteroid dependency, hospitalisation and colectomy. Smoking cessation was not associated with worse disease course. The risks associated with smoking outweigh any benefits. UC patients should be counselled against smoking.
引用
- Blackwell J, Saxena S, Alexakis C, et al. The impact of smoking and smoking cessation on disease outcomes in ulcerative colitis: a nationwide population-based study. Aliment Pharmacol Ther. 2019. PMID: 31389044. doi:10.1111/apt.15390
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。